3 ASX 200 directors buying up their company shares this week

Three ASX 200 directors have bolstered holdings in their respective companies.

| More on:
A businesswoman stands with arms crossed in a powerful pose with the city buildings behind her.

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Insiders appear to be backing these S&P/ASX 200 Index (ASX: XJO) shares, with three directors bolstering holdings in their own companies this week.

Insider buying is generally a good sign that those in the know believe their company's stock is trading at a reasonable price. It can also be an indication that those working behind the scenes have confidence in their business.

So, which ASX 200 shares seemingly appear attractive to those in the know? Keep reading to find out.

3 ASX 200 shares being bought by insiders this week

The largest insider purchase of the three ASX 200 shares by value was made by Cochlear Limited (ASX: COH) director Michael del Prado.

The director forked out US$192,000 on 150 shares in the hearing implant device manufacturer, paying US$128 apiece to do so, on Tuesday.

The purchase was made on the United States over-the-counter market and boosted Prado's holding in the company to 450 shares.

The largest by number of shares was an indirect on-market trade of 15,000 shares in Iluka Resources Limited (ASX: ILU).

Chair of the mineral sands miner, Rob Cole, was behind the purchase, made on Monday. He paid a total of $130,654.14 for the parcel, representing around $8.71 per share. The insider now holds 37,000 shares in the company.

The buy has already turned a slight return. The Iluka share price is trading at $8.79 right now.

The final ASX 200 insider buying shares in their own company this week is IGO Ltd (ASX: IGO) director Justin Osborne.

He indirectly bought 10,000 shares in the diversified metals miner on Tuesday, spending a combined $148,350 to do so. That equates to around $14.835 per stock.

Unfortunately for Osborne, the company's share price has since slipped. Buying into the company right now would see an investor pay $14.74 a share. That's 0.6% less than the director's purchase price.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another red day on the markets this Wednesday.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Northern Star, Pro Medicus, and Web Travel shares

How does the team at Morgans rate these popular shares? Let's find out.

Read more »

Multiracial happy young people stacking hands outside - University students hugging in college campus - Youth community concept with guys and girls standing together supporting each other.
Share Gainers

Why 4DMedical and these ASX shares are up 200%+ in just a year

These shares have made their shareholders wealthy over the past year.

Read more »

Four people on the beach leap high into the air.
Opinions

4 reasons why I think BHP shares are a must-buy for 2026

The mining giant's shares are now 20% higher than this time last year.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A few gold nullets sit on an old-fashioned gold scale, representing ASX gold shares.
Broker Notes

Up 300% since August, why this surging ASX gold stock could keep racing higher

A leading broker forecasts more strong outperformance from this rocketing ASX gold stock.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why 29Metals, Navigator Global, Praemium, and Xero shares are sinking today

These shares are having a tough time on hump day. But why?

Read more »